• Mundipharma agrees $250m ‘smart chemotherapy’ deal pharmafile
    August 16, 2017
    A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits of their labour, with Mundipharma swooping to take CAP7.I into Phase 3 trials.
PharmaSources Customer Service